tiprankstipranks
China Pharma Holdings (CPHI)
NYSE MKT:CPHI
US Market

China Pharma Holdings (CPHI) Stock Price & Analysis

246 Followers

CPHI Stock Chart & Stats

Day’s Range$0.3 - $0.32
52-Week Range― - ―
Previous Close$0.33
Volume233.06K
Average Volume (3M)N/A
Market Cap
$4.70M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
BetaN/A
May 16, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Risk Analysis

Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks

Website Traffic

Sorry, No Data Available
There is no website visitor data available for this stock.
---

CPHI FAQ

What was China Pharma Holdings’s price range in the past 12 months?
Currently, no data Available
What is China Pharma Holdings’s market cap?
Currently, no data Available
When is China Pharma Holdings’s upcoming earnings report date?
China Pharma Holdings’s upcoming earnings report date is May 16, 2024 which is in 19 days.
    How were China Pharma Holdings’s earnings last quarter?
    China Pharma Holdings released its earnings results on Nov 17, 2023. The company reported -$0.059 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.059.
      Is China Pharma Holdings overvalued?
      According to Wall Street analysts China Pharma Holdings’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does China Pharma Holdings pay dividends?
        China Pharma Holdings does not currently pay dividends.
        What is China Pharma Holdings’s EPS estimate?
        China Pharma Holdings’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does China Pharma Holdings have?
        Currently, no data Available
        What happened to China Pharma Holdings’s price movement after its last earnings report?
        China Pharma Holdings reported an EPS of -$0.059 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -2.174%.
          Which hedge fund is a major shareholder of China Pharma Holdings?
          Currently, no hedge funds are holding shares in CPHI
          ---

          China Pharma Holdings Stock Smart Score

          N/A
          Not Ranked
          1
          2
          3
          4
          5
          6
          7
          8
          9
          10

          Technicals

          SMA
          Negative
          20 days / 200 days
          Momentum
          -80.82%
          12-Months-Change

          Fundamentals

          Return on Equity
          -52.43%
          Trailing 12-Months
          Asset Growth
          -7.39%
          Trailing 12-Months

          Company Description

          China Pharma Holdings

          China Pharma Holdings, Inc. engages in the development, manufacture, and marketing of pharmaceutical products. It caters people with cardiovascular, central nervous system, infectious, and digestive diseases. The company was founded by Zhi Lin Li on January 28, 1999 and is headquartered in Haikou, China.
          ---
          Similar Stocks
          Company
          Price & Change
          Follow
          Assertio Therapeutics
          Traws Pharma
          Bio-Path Holdings
          Popular Stocks
          ---
          What's Included in PREMIUM?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis